Scandinavian Real Heart
0.818 SEK -2.15%Be the first to follow this company
Scandinavian Real Heart operates in medical technology. Today, the company's main focus is on research and development of heart pumps used among patients with severe heart conditions who are in the queue for transplant. The idea behind the heart pump is to use the product as a transitional solution before a final heart transplant is performed. The company is based in Västerås.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
HEART
Daily low / high price
0.8 / 0.848
SEK
Market cap
79.34M SEK
Turnover
182.29K SEK
Volume
226K
Financial calendar
Interim report
2024-05-08
General meeting
2024-06-13
Interim report
2024-08-22
Interim report
2024-11-14
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
European Innovation Council Accelerator | 18.9 % | 18.9 % |
Eskilstunahem Förvaltnings AB | 8.1 % | 8.1 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Realheart Reports Results From Another Successful Preclinical Trial With the Artificial Heart Realheart® TAH
Realheart Presents Positive Hematological Data at the American Society for Artificial Internal Organs 70th Annual Conference in Baltimore
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools